The trading price of Zevia PBC (NYSE:ZVIA) floating higher at last check on current market day and closing at $3.19, 11.93% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $2.91 and $3.3695. In examining the 52-week price action we see that the stock hit a 52-week high of $2.99 and a 52-week low of $0.62. Over the past month, the stock has gained 165.83% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zevia PBC, whose market valuation is $237.07 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.06 per share this quarter, however they have predicted annual earnings per share of -0.3 for current year and -0.22 for next year.
Analysts have forecast the company to bring in revenue of 39.13M for the current quarter, with the likely lows of 38.7M and highs of 39.5M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 154.79M.
On the technical side, indicators suggest ZVIA has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned ZVIA a recommendation rating is 2. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Zevia PBC (ZVIA) as Underweight, while 1 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that ZVIA’s price is currently 38.16% off the SMA20 and 99.28% off the SMA50. The RSI metric on the 14-day chart is currently showing 76.10, and weekly volatility stands at 16.43%. When measured over the past 30 days, the indicator reaches 17.10%. Zevia PBC (NYSE:ZVIA)’s beta value is currently sitting at 1.02, while the Average True Range indicator is currently displaying 0.30. With analysts defining $2-$2 as the low and high price targets, we arrive at a consensus price target of $2 for the trailing 12-month period. The current price is about 37.3% off the estimated low and 37.3% off the forecast high, based on this estimate. Investors will be thrilled if ZVIA’s share price rises to $2, which is the median consensus price. At that level, ZVIA’s share price would be 37.3% above current price.
To see how Zevia PBC stock has been performing today in comparison to its peers in the industry, here are the numbers: ZVIA stock’s performance was 11.93% at last check in today’s session, and 58.71% in the past year.
An evaluation of the daily trading volume of Zevia PBC (NYSE:ZVIA) indicates that the 3-month average is 400.38K. However, this figure has increased over the past 10 days to an average of 0.79.
Currently, records show that 59.85 million of the company’s shares remain outstanding. The insiders hold 25.15% of outstanding shares, whereas institutions hold 44.58%. The stats also highlight that short interest as of 2024-11-15, stood at 0.5 million shares, resulting in a short ratio of 0.97 at that time. From this, we can conclude that short interest is 189.00 of the company’s total outstanding shares. It is noteworthy that short shares in November were down slightly from the previous month’s figure, which was 0.72 million. However, since the stock’s price has seen 58.71% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
